Orchid Pharma Ltd.

1056.10 +2.60 ▲0.3%

23 April 2024, 04:02:42 PM
Volume: 59,388

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.orchidpharma.com
Market Cap 5,369.89 Cr.
Enterprise Value(EV) 5,434.10 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 23.22 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 45.59 Trailing Twelve Months Ending 2023-12
Industry PE 41.25 Trailing Twelve Months Ending 2023-12
Book Value / Share 224.38 Trailing Twelve Months Ending 2023-12
Price to Book Value 4.72 Calculated using Price: 1,058.75
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 5.07 Cr. 50,719,105 Shares
FaceValue 10
About Orchid Pharma Ltd.
Orchid Chemicals & Pharmaceuticals (Orchid) is pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was Incorporated in the year 1992 as a 100% export-oriented unit (EOU).

Orchid Pharma Ltd. Delivery

Delivered Qty
Traded Qty

Orchid Pharma Ltd. Performance

1 Day
+0.25%
1 Week
-3.90%
1 Month
-0.03%
3 Month
+42.29%
6 Month
+123.77%
1 Year
+173.11%
2 Year
+178.18%
5 Year
+19101.82%
10 Year
+1764.25%

Orchid Pharma Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -55.58 -147.51 0 0 0 -225 -13.43 -8.75 8.27
Return on Capital Employed (%) 4.17 -0.06 -6.93 -3.46 3.08 -3.29 -3.53 -2.32 9.11
Return on Assets (%) -4.53 -7.05 -13.59 -10.88 2.24 -3.07 -7.06 -4.85 4.73

Orchid Pharma Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 329 49 -388 -792 -704 766 653 647 689 1,108
Non Curr. Liab. 2,609 2,475 2,205 1,905 1,436 519 442 222 165 145
Curr. Liab. 1,123 1,338 1,541 2,013 2,346 175 142 241 372 239
Minority Int.
Equity & Liab. 4,061 3,862 3,358 3,125 3,077 1,460 1,237 1,111 1,225 1,492
Non Curr. Assets 2,783 2,611 2,479 2,446 2,310 891 687 713 724 995
Curr. Assets 1,278 1,251 879 679 767 569 429 384 501 497
Misc. Exp. not W/O
Total Assets 4,061 3,862 3,358 3,125 3,077 1,460 1,237 1,111 1,225 1,492

Orchid Pharma Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 1,747 873 797 683 600 484 450 560 666 812
Other Income 42 25 19 20 17 24 15 9 19 20
Total Income 1,789 898 816 703 617 508 465 569 685 832
Total Expenditure -1,429 -703 -709 -659 -612 -454 -399 -505 -582 -692
PBIDT 360 196 106 45 5 54 66 64 104 140
Interest -537 -294 -331 -310 -7 -6 -52 -33 -33 -20
Depreciation -325 -145 -141 -133 -130 -118 -109 -87 -55 -32
Taxation 191 17 48 46
Exceptional Items 113 -53 -173 201 39 39
PAT -197 -279 -490 -353 69 -70 -95 -57 55 127
Minority Interest 1
Share Associate 0 -4 -2 -2
Other Related Items
Consolidated Net Profit -197 -279 -490 -353 69 -131 -117 -2 46 118
Adjusted EPS -23 -31 -55 -40 8 -32 -29 0 11 26

Orchid Pharma Ltd. Cash Flow

Particulars 10 years 2013-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 168 -369 212 317 9 12 81 24 92 18
Cash Fr. Inv. -986 1,334 -1 -9 -28 45 167 67 113 -31
Cash Fr. Finan. 664 -597 -286 -366 33 0 -250 -165 -217 31
Net Change -153 367 -76 -58 15 57 -2 -74 -11 18
Cash & Cash Eqvt 23 391 315 257 35 92 90 16 4 23

Orchid Pharma Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 90.00 89.96 89.96 89.96 89.96 72.40 72.40 69.84 69.84
Public 10.00 10.04 10.04 10.04 10.04 27.60 27.60 30.16 30.16
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Orchid Pharma Ltd. Announcements

Mon, 15 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Orchid Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Fri, 12 Apr 2024
Resignation of Independent director
ORCHID PHARMA LIMITED has informed the Exchange about Resignation of Independent director.
Fri, 12 Apr 2024
Resignation
Orchid Pharma Limited has informed the Exchange regarding Resignation of Mr Mudit Tandon as Independent Director of the company w.e.f. April 12, 2024.

Orchid Pharma Ltd. Technical Scans

Mon, 22 Apr 2024
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years
High Increase in 5 Years High Increase in 5 Years

Orchid Pharma Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 369,401.61 1,484.65 -3.6%
Cipla Ltd. 109,341.46 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. 100,341.19 5,952.10 -1.1%
Divi's Laboratories Ltd. 99,176.41 3,768.65 +0.8%
Zydus Lifesciences Ltd. 96,543.12 959.45 0.0%
Mankind Pharma Ltd. 93,651.57 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. 89,650.45 6,194.90 -0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.48 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 29.49 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.19 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-12 71.71 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.46 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 54.22 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 113.58 6,194.90 -0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.92 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 4.22 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.73 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-12 7.61 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.12 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.54 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.27 6,194.90 -0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,194.90 -0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,194.90 -0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,194.90 -0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,194.90 -0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,194.90 -0.7%

Orchid Pharma Ltd. FAQ's

What is Orchid Pharma share price?

Can I buy Orchid Pharma shares now?

What is the Market Cap of Orchid Pharma?

What are the key metrics to analyse Orchid Pharma?

What is the 52 Week High and Low of Orchid Pharma?

What is the trend of Orchid Pharma share price?